SEC Filing Summary: CopyTele, Inc. (10-Q)
Business Context and Reporting Period
This report covers the quarterly period ended April 30, 2000, for CopyTele, Inc. (Note: The input metadata referenced "Anixa Biosciences," but the filing text explicitly identifies the registrant as CopyTele, Inc.). The company is classified as a Development Stage Enterprise focused on developing, producing, and marketing multi-functional encryption and telecommunications products, specifically the USS-900 (digital encryption system) and the SCS-700 (secure communication system). The company also maintains a 55% owned joint venture in Shanghai, China (Shanghai CopyTele).
Key Financial Metrics
| Metric | Six Months Ended April 30, 2000 |
Six Months Ended April 30, 1999 |
Inception through April 30, 2000 |
|---|---|---|---|
| Sales | $698,392 | $0 | $745,269 |
| Gross Profit | $306,813 | $0 | $316,386 |
| Net Loss | $(2,581,049) | $(3,028,455) | $(52,740,974) |
| Net Loss Per Share (Basic/Diluted) | $(0.04) | $(0.05) | $(1.10) |
| Cash and Equivalents (Ending) | $3,588,909 | $3,741,737 | $3,588,909 |
| Working Capital | $7,234,856 | $5,726,808 | N/A |
| Net Tangible Assets | $7,664,487 | $6,284,777 | N/A |
| Operating Cash Flow | $(2,210,953) | $(2,641,981) | $(53,005,095) |
Debt and Liquidity: The company has no long-term debt listed on the balance sheet. Liquidity is maintained through cash reserves and proceeds from stock sales. The company holds approximately $3.6 million in cash and marketable securities.
Material Changes vs. Prior Period
- Revenue Generation: The company recognized sales of approximately $698,000 for the six months ended April 30, 2000, compared to zero sales in the same period in 1999. This marks the first significant revenue recognition in the company's history.
- Expense Reduction: Selling, general, and administrative (SG&A) expenses decreased by approximately $136,000 (from $3.01 million to $2.88 million) compared to the prior six-month period. This reduction was driven by lower compensation costs, reduced engineering supplies, and decreased R&D spending on video/color flat panel displays.
- Inventory Charge: A non-cash charge of $250,000 was recorded in the quarter to adjust inventory valuation to net realizable value and account for obsolete parts.
- Joint Venture Losses: The loss from the Shanghai CopyTele joint venture decreased to $64,040 for the six months ended April 30, 2000, compared to $113,095 in the prior year period, due to cost reductions and limited production activity.
Guidance, Outlook, and Risks
- Liquidity Outlook: Management believes current cash resources, combined with recent proceeds, are sufficient to fund operations into the third quarter of fiscal 2001. Beyond that, the company anticipates a need for additional funding to support marketing and R&D.
- Financing Needs: The company may need to raise additional equity or debt to maintain its NASD listing requirement of $4 million in net tangible assets (currently at $7.66 million) and to fund ongoing operations. No definitive financing arrangements are in place.
- Key Risks:
- Development Stage Status: The company has incurred cumulative losses of over $52 million since inception and has limited sales history.
- Product Obsolescence: Success depends on the ability to market encryption products and secure supply chains for critical components (e.g., Harris Corporation chips).
- Joint Venture Uncertainty: The Shanghai joint venture has incurred cumulative losses of over $2.1 million. The company has recorded a permanent impairment on its investment and discontinued recording its share of losses.
- Inventory Valuation: There is no assurance that inventory can be sold at current carrying values; further write-downs may be necessary.
- Management Commentary: The company is actively marketing the USS-900 and SCS-700 to government agencies and security organizations. Senior executives have waived salaries and pension benefits to conserve cash.
Investor Verification Checklist
- Verify the company's ability to generate sufficient sales volume to cover operating costs and emerge from development stage status.
- Confirm the status of the supply agreement for the Harris Corporation "Citadel" encryption chip used in the USS-900.
- Monitor the financial health and operational progress of the Shanghai CopyTele joint venture, given the history of losses and impairment.
- Assess the company's ability to raise additional capital if required to meet NASD listing requirements or fund operations beyond Q3 fiscal 2001.
- Review future inventory valuation adjustments, as the company has already recorded a $250,000 charge for obsolete parts and valuation alignment.